Abstract Search System
Strategic International Session (Symposium)1 (JSGE)
November 4, 9:00–12:00, Room 9 (Portopia Hotel Main Building Kairaku 3)
JSGE・UEGW Joint Symposium：Lifestyle-related disease in digestive system
Allotted time: 30 min, for oral presentation, 10 min. for Q&A
Discussion: Not to be held
Introductory Meeting: Not to be held
Discussion: Not to be held
Introductory Meeting: Not to be held
-
Chairperson:
Shin FukudoDepartment of Behavioral Medicine, Tohoku University Graduate School of Medicine
-
Chairperson:
Atsushi NakajimaDepartment of Gastroenterology and Hepatology, Yokohama City University School of Medicine
ST-S1-1_G
ST-S1-2_G
IBS and nutrition
ST-S1-3_G
Effective Utilization of Noninvasive Tests for Rule-out and Rule-in Strategy for the Treatment of Nonalcoholic Fatty Liver Disease in a Hepatology Center
ST-S1-4_G
Impact of Lifestyle on Irritable Bowel Syndrome
Strategic International Session (Symposium)2 (JSGS, JSGE)
November 5, 9:30–11:30, Room 9 (Portopia Hotel Main Building Kairaku 3)
Treatment strategy for locally advanced rectal cancer - LLND・NACRT・NAC・watch-and-wait
Time Slot for Each Speaker: (Time slots vary depending on presentations. Please prepare your presentation as below.)
ST-S2-1_S : 20 min. for oral presentation, 5 min. for Q&A
Other Presentations: 15 min. for oral presentation, 4 min. for Q&A
Discussion: Not to be held
Introductory Meeting: Not to be held
ST-S2-1_S : 20 min. for oral presentation, 5 min. for Q&A
Other Presentations: 15 min. for oral presentation, 4 min. for Q&A
Discussion: Not to be held
Introductory Meeting: Not to be held
-
Chairperson:
Tadahiko MasakiShimizugaoka Hospital
-
Chairperson:
Shigeki YamaguchiDepartment of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University
-
Discussant:
Tsuyoshi KonishiThe University of Texas MD Anderson Cancer Center
-
Discussant:
Jeffrey MilsomWeill Cornell Medicine / New York Presbyterian Hospital
ST-S2-1_S
Treatment strategy for rectal cancer in MD Anderson Cancer Center
ST-S2-2_S
Stratification for the risk of lateral lymph node metastasis of locally advanced rectal cancer
ST-S2-3_S
Short-term results of neoadjuvant radiation therapy for patients with locally advanced rectal cancer
ST-S2-4_S
Personalized treatment strategies for locally advanced rectal cancer with using modified short-course preoperative chemoradiotherapy
ST-S2-5_S
Standardization of surgical treatment for advanced lower rectal cancer and efforts for future individualization
ST-S2-6_S
Strategy based on neoadjuvant chemotherapy (NAC) for locally advanced rectal cancer and the new predictive marker for its response; the lymphocyte ratio before and after NAC.
Strategic International Session (Symposium)3 (JSH)
November 5, 9:00–12:00, Room 10 (Portopia Hotel Main Building Waraku)
JSH-AASLD joint symposium: Basic and clinical research on NASH-related HCC
Time Slot for Each Speaker: (Time slots vary depending on presentations. Please prepare your presentation as below.)
ST-S3-1_H, ST-S3-2_H, ST-S3-3_H, ST-S3-4_H: 25 min. for oral presentation, 10 min. for Q&A
Other Presentations: 15 min. for oral presentation
Discussion: Not to be held
Introductory Meeting: Not to be held
ST-S3-1_H, ST-S3-2_H, ST-S3-3_H, ST-S3-4_H: 25 min. for oral presentation, 10 min. for Q&A
Other Presentations: 15 min. for oral presentation
Discussion: Not to be held
Introductory Meeting: Not to be held
-
Chairperson:
Tatsuya KantoThe Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine
-
Chairperson:
Manal Abdelmalek NAFLD Clinical Research Program, Duke University
-
Discussant:
Hayato NakagawaDepartment of Gastroenterology and Hepatology, Mie University Graduate School of Medicine
-
Discussant:
Rohit Loomba Division of Gastroenterology and Hepatology Department of Medicine, University of California San Diego